• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.13% Nasdaq Down0.93%

    Synageva BioPharma Corp. (GEVA)

    -NasdaqGS
    115.32 Down 4.45(3.72%) 4:00PM EST
    |After Hours : 115.32 0.00 (0.00%) 4:38PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 1,326   2,343   1,586   3,474  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,326   2,343   1,586   3,474  
    Operating Expenses
    Research Development34,605  39,528  27,868  25,176  
    Selling General and Administrative14,441  12,591  9,804  8,866  
    Non Recurring -   -   -   -  
    Others318  537  390  376  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (48,038) (50,313) (36,476) (30,944)
    Income from Continuing Operations
    Total Other Income/Expenses Net(265)89  70  (86)
    Earnings Before Interest And Taxes(48,303)(50,224)(36,406)(30,688)
    Interest Expense -   -   -   -  
    Income Before Tax(48,303)(50,224)(36,406)(30,688)
    Income Tax Expense16  16  18  48  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(48,319)(50,240)(36,424)(30,736)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (48,319) (50,240) (36,424) (30,736)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (48,319) (50,240) (36,424) (30,736)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.